BibTex RIS Kaynak Göster

DEGETAM’a Yönlendirilen Hastalardaki MEFV Geni Mutasyonlarının Dağılımı,

Yıl 2009, Cilt: 23 Sayı: 2, 53 - 58, 01.08.2009

Öz

Kaynakça

  • 1. Livhen A, Langevitz P, Zemer D et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40: 1879-1885.
  • 2. International FMF Consortium: Ancient missense mutations in a new member of the RoRetgene family are likely to cause familial Mediterranean fever. Cell 1997; 90: 797-807.
  • 3. Shoham NG, Centola M, Mansfield E, et al. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Nat Acad Sci 2003; 100: 13501- 13506.
  • 4. Yu JW, Fernandes-Alnemri T, Datta P et al. Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants. Molec Cell 2007; 28: 214-227.
  • 5. INFEVERS The registry of Familial Mediterranean fever (FMF) and heraditary Autoinflammatory Disorders Mutations. http://fmf.igh.cnrs.fr/infevers/.Accesed 11 Mar 2008.
  • 6. Jarjour RA. Familial Mediterranean fever in Syrian patients: MEFV gene mutations and genotype-phenotype correlation. Mol Biol Rep 2009; Published online:March.
  • 7. Touitou I. Standardized testing for mutations in familial Mediterranean fever. Clin Chem 2003; 49: 1781-1782.
  • 8. Ozen S. Vasculopathy, BehcËet's syndrome, and familial Mediterranean fever. Curr Opin Rheumatol 1999; 11: 393-398.
  • 9. Akar N, Misiroğlu M, Yalcinkaya F et al. MEFV mutations in Turkish patients suffering from familial Mediterranean fever. Hum Mut 2000; 15:118-119.
  • 10. Yalcinkaya F, Tekin M, Çakar N, Akar E, Akar N, Tümer N. Familial Mediterranean fever and systemic amyloidosis in untreated Turkish patients. Q J Med 2000; 93:681.
  • 11. Yilmaz, E, Ozen, S, Balci, B, et al. Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Europ J Hum Genet 2001; 9: 553-555.
  • 12. Güran Ş, Gök F, Erdem H, Erdil A, Yakıcıer C, Dursun A, Orkunoğlu FE, Đmirzalıoğlu N. Ailesel Akdeniz Ateşi- “Familial Mediterranean Fever-FMF” düşünülen olgularda MEFV gen mutasyonları. Moleküler Tanı Dergisi 2003;1:42-44.
  • 13. Olgun A, Akman S, Kurt I, Tuzun A, Kutluay T. MEFV mutations in familial Mediterranean fever: association of M694V homozygosity with arthritis. Rheumatol Int 2005;25:255-259.
  • 14. Oberkanins C, Weinhausel A, Kriegshauser G, Moritz A, Kury F, Haas OA. Genetic testing for familial Mediterranean fever in Austria by means of reversehybridization test strips. Clin Chem 2003;49:1948-1950.
  • 15. Tchernitchko D, Legendre M, Delahaye A et al. Clinical evaluation of a reverse hybridization assay for the molecular detection of twelve MEFV gene mutations. Clin Chem 2003;49:1942-1945.
  • 16. Turkish FMF Study Group. Familial Mediterranean fever (FMF) in Turkey: Results of a nationwide multicenter study. Medicine, 2005; 84:1–11.
  • 17. Yalçınkaya F, Çakar N, Mısırlıoglu M4, et al. Genotypephenotype correlation in a large group of Turkish patients with familial Mediterranean fever: Evidence for mutation independent amyloidosis. Rheumatology 2000; 39:67–72.
  • 18. Gunesacar R, Kasap H, Erken E, Ozer H. Comparison of Amplification Refractory Mutation System and Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Techniques Used for the Investigation of MEFV Gene Exon 10 Point Mutations in Familial MediterraneanFever Patients Living in Çukurova Region (Turkey). Genetic Testing 2005;9:220-225.
  • 19. Pasa S, Altintas A, Devecioglu B et al. Familial Mediterranean fever gene mutations in the Southeastern region of Turkey and their phenotypical features. Amyloid 2008; 15:49–53.
  • 20. Toutiou I The spectrum of Familial Mediterranean Fever (FMF) mutations. Eur J Hum Genet 2001; 9:473–483.
  • 21. Demirkaya E, Tunca Y, Gok F, Ozen S, Gul D. A veryfrequent mutation and remarkable association of R761H withM694V mutations in Turkish familial Mediterranean fever patients. Clin Rheumatol 2008; 27:729– 732.
  • 22. Akin H, Onay H, Turker E, Cogulu O, Ozkinay F. MEFV mutations in patients with familial Mediterranean fever from the Aegean region of Turkey. Mol Biol Rep DOI 10.1007/s11033-009-9543-9531
  • 23. Gunel-Ozcan A, Sayın DB, Mısırlıoglu E, Güliter S, Yakaryilmaz F, Ensari C. The spectrum of FMF mutations and genotypes in the referrals to molecular genetic laboratory at Kırıkkale University in Turkey. Mol Biol Rep (2009) 36:757–760 DOI 10.1007/s11033-008- 9240-9245.
  • 24. Gkretsi V, Deltas C, Yapijakis C, Lamnissou K. Screening for Familial Mediterranean Fever M694V and V726A mutations in the Greek population. Genet Test Mol Biomarkers. 2009; 13: 291-293.

DEGETAM’a Yönlendirilen Hastalardaki MEFV Geni Mutasyonlarının Dağılımı,

Yıl 2009, Cilt: 23 Sayı: 2, 53 - 58, 01.08.2009

Öz

Amaç: Ailesel Akdeniz ateşi (FMF), Akdeniz civarındaki ülkelerde görülen otozomal resesif geçişli kalıtsal bir hastalıktır. FMF bulunan hastalar tekrarlayan ateşle birlikte karın ve eklem ağrıları, artrit gibi klinik bulgular göstermektedir. MEFV genindeki missense mutasyonların hastalıktan sorumlu olduğu gösterilmiştir. Çalışmamızda, 1679 Türk hasta ve taşıyıcıdaki 12 yaygın MEFV geni mutasyonunun dağılımını ve sıklığını göstermeyi hedefledik. Gereç ve yöntem: Strip assay metodu kullanılarak MEFV gene mutasyonları araştırıldı: E148Q (ekon 2), P369S (ekon 3), F479L (ekon 5), and M680I (G/C), M680I (G/A), I692del, M694V, M694I, K695R, V726A, A744S, R761H (ekzon 10). Bulgular: Sekizyüzkırkdokuz hastada (%50,56) MEFV geni mutasyonu saptanır-ken, 830 (% 49,44) hastada mutasyon saptanmadı. Mutasyonlu 849 olgunun, 133 (7,92%) tanesi mutasyonlar açısından homozigot, 231 (%13,76) tanesi compound heterozigot ve 479 (%28,52) olgu heterozigot olarak bulundu. Altı hastada kompleks genotip gözlendi (%0,36). En sık rastlanan mutasyonlar M694V ve sırası ile E148Q, M680I (G/C), V726A olarak bulundu. Ayrıca bu mutasyonlar dışında nadir olarak görülen mutasyonlar da saptandı. Sonuç: Çalışmamızın sonucunda, MEFV geni için yaygın görülen mutasyonların dağılımını, Türk FMF’li hasta grupları arasında yapılan diğer çalışmalar ile benzer, ancak mutasyon oranlarını düşük bulduk

Kaynakça

  • 1. Livhen A, Langevitz P, Zemer D et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40: 1879-1885.
  • 2. International FMF Consortium: Ancient missense mutations in a new member of the RoRetgene family are likely to cause familial Mediterranean fever. Cell 1997; 90: 797-807.
  • 3. Shoham NG, Centola M, Mansfield E, et al. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Nat Acad Sci 2003; 100: 13501- 13506.
  • 4. Yu JW, Fernandes-Alnemri T, Datta P et al. Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants. Molec Cell 2007; 28: 214-227.
  • 5. INFEVERS The registry of Familial Mediterranean fever (FMF) and heraditary Autoinflammatory Disorders Mutations. http://fmf.igh.cnrs.fr/infevers/.Accesed 11 Mar 2008.
  • 6. Jarjour RA. Familial Mediterranean fever in Syrian patients: MEFV gene mutations and genotype-phenotype correlation. Mol Biol Rep 2009; Published online:March.
  • 7. Touitou I. Standardized testing for mutations in familial Mediterranean fever. Clin Chem 2003; 49: 1781-1782.
  • 8. Ozen S. Vasculopathy, BehcËet's syndrome, and familial Mediterranean fever. Curr Opin Rheumatol 1999; 11: 393-398.
  • 9. Akar N, Misiroğlu M, Yalcinkaya F et al. MEFV mutations in Turkish patients suffering from familial Mediterranean fever. Hum Mut 2000; 15:118-119.
  • 10. Yalcinkaya F, Tekin M, Çakar N, Akar E, Akar N, Tümer N. Familial Mediterranean fever and systemic amyloidosis in untreated Turkish patients. Q J Med 2000; 93:681.
  • 11. Yilmaz, E, Ozen, S, Balci, B, et al. Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Europ J Hum Genet 2001; 9: 553-555.
  • 12. Güran Ş, Gök F, Erdem H, Erdil A, Yakıcıer C, Dursun A, Orkunoğlu FE, Đmirzalıoğlu N. Ailesel Akdeniz Ateşi- “Familial Mediterranean Fever-FMF” düşünülen olgularda MEFV gen mutasyonları. Moleküler Tanı Dergisi 2003;1:42-44.
  • 13. Olgun A, Akman S, Kurt I, Tuzun A, Kutluay T. MEFV mutations in familial Mediterranean fever: association of M694V homozygosity with arthritis. Rheumatol Int 2005;25:255-259.
  • 14. Oberkanins C, Weinhausel A, Kriegshauser G, Moritz A, Kury F, Haas OA. Genetic testing for familial Mediterranean fever in Austria by means of reversehybridization test strips. Clin Chem 2003;49:1948-1950.
  • 15. Tchernitchko D, Legendre M, Delahaye A et al. Clinical evaluation of a reverse hybridization assay for the molecular detection of twelve MEFV gene mutations. Clin Chem 2003;49:1942-1945.
  • 16. Turkish FMF Study Group. Familial Mediterranean fever (FMF) in Turkey: Results of a nationwide multicenter study. Medicine, 2005; 84:1–11.
  • 17. Yalçınkaya F, Çakar N, Mısırlıoglu M4, et al. Genotypephenotype correlation in a large group of Turkish patients with familial Mediterranean fever: Evidence for mutation independent amyloidosis. Rheumatology 2000; 39:67–72.
  • 18. Gunesacar R, Kasap H, Erken E, Ozer H. Comparison of Amplification Refractory Mutation System and Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Techniques Used for the Investigation of MEFV Gene Exon 10 Point Mutations in Familial MediterraneanFever Patients Living in Çukurova Region (Turkey). Genetic Testing 2005;9:220-225.
  • 19. Pasa S, Altintas A, Devecioglu B et al. Familial Mediterranean fever gene mutations in the Southeastern region of Turkey and their phenotypical features. Amyloid 2008; 15:49–53.
  • 20. Toutiou I The spectrum of Familial Mediterranean Fever (FMF) mutations. Eur J Hum Genet 2001; 9:473–483.
  • 21. Demirkaya E, Tunca Y, Gok F, Ozen S, Gul D. A veryfrequent mutation and remarkable association of R761H withM694V mutations in Turkish familial Mediterranean fever patients. Clin Rheumatol 2008; 27:729– 732.
  • 22. Akin H, Onay H, Turker E, Cogulu O, Ozkinay F. MEFV mutations in patients with familial Mediterranean fever from the Aegean region of Turkey. Mol Biol Rep DOI 10.1007/s11033-009-9543-9531
  • 23. Gunel-Ozcan A, Sayın DB, Mısırlıoglu E, Güliter S, Yakaryilmaz F, Ensari C. The spectrum of FMF mutations and genotypes in the referrals to molecular genetic laboratory at Kırıkkale University in Turkey. Mol Biol Rep (2009) 36:757–760 DOI 10.1007/s11033-008- 9240-9245.
  • 24. Gkretsi V, Deltas C, Yapijakis C, Lamnissou K. Screening for Familial Mediterranean Fever M694V and V726A mutations in the Greek population. Genet Test Mol Biomarkers. 2009; 13: 291-293.
Toplam 24 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Makaleler
Yazarlar

A. Ülgenalp Bu kişi benim

Yayımlanma Tarihi 1 Ağustos 2009
Gönderilme Tarihi 11 Ağustos 2015
Yayımlandığı Sayı Yıl 2009 Cilt: 23 Sayı: 2

Kaynak Göster

Vancouver Ülgenalp A. DEGETAM’a Yönlendirilen Hastalardaki MEFV Geni Mutasyonlarının Dağılımı,. DEU Tıp Derg. 2009;23(2):53-8.